Methylene Blue: Approved for a Poisoning Emergency. Fatal Cases Described With Antidepressants.
Methylene blue is not a supplement. It is a drug, and it is approved by the Food and Drug Administration to treat exactly one thing.
Methemoglobinemia — a poisoning in which the blood loses its ability to carry oxygen. [1] It is an emergency, it happens in hospitals, and methylene blue is the antidote.
It is now sold in dropper bottles to people who want more energy.
We are not telling you to stop any medicine your doctor prescribed. We are telling you that this is a conversation to have with them before anything else.
The hospital evidence is real, and it is worth stating properly
We are not going to pretend this is snake oil, because it isn’t.
Beyond the poisoning indication, methylene blue is used in vasoplegic shock, in a specific chemotherapy complication, and as a surgical stain. [1] And there is genuinely interesting recent work on preventing the confusion and memory problems that follow major surgery in older patients — a problem affecting somewhere between 15% and 40% of them. [3]
In randomised trials, a single intravenous dose given during the operation cut the rate of post-operative delirium from 24% to 7%. [3] That is a large effect on a serious problem.
Now notice everything that sentence contains
Intravenous. Single dose. Weight-calculated. Given during surgery, by an anaesthetist, to elderly patients under monitoring, in a hospital.
None of those words describe a dropper bottle and a glass of water.
This is the move the whole category runs on, and it is worth naming because you will see it again: a real drug with real uses is not the same thing as a supplement, and the evidence for the first does not transfer to the second. The review that reports the delirium result is a narrative one, and its own authors call for large multicentre trials before methylene blue’s role is considered established. [3]
For the thing actually being sold — drops in water, for energy, in healthy people — we did not find trials.
The interaction, in the reference’s own words
This is the part of the page that matters most, so here it is verbatim.
“Serotonin syndrome has been reported following administration of methylene blue, particularly when used concomitantly with medications that increase serotonergic activity, including selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and monoamine oxidase inhibitors; certain opioids; and dextromethorphan. The risk is increased with concurrent use, and fatal cases have been described.” [1]
And the instruction that follows it: “Concomitant use of methylene blue with serotonergic agents and opioids should be avoided.” [1]
SSRIs and SNRIs are among the most widely prescribed medicines in the world. Dextromethorphan is in cough syrup. This is not an obscure interaction between two rare drugs — it is an interaction between a wellness product and a very ordinary prescription.
And a second contraindication most buyers have never heard of
Methylene blue is contraindicated in people with G6PD deficiency — an inherited enzyme difference — because of the risk of haemolysis, the destruction of red blood cells. [1]
The awkward part is that plenty of people who have it do not know they have it. It is not something you would find out from a wellness video, and the bottle will not ask.
One more line, for a specific reader
The NIH’s lactation database has an entry. It notes that current labelling says “breastfeeding should be discontinued during and for up to 8 days after administration”. [2]
And then: “No information is available on the safety of oral methylene blue during breastfeeding.” [2] Oral being the exact route the dropper bottle uses.
The verdict
Unsupported, for the energy and wellness claims. We looked for trials of methylene blue given to healthy people for the reasons it is being sold, and did not find them. What exists is a real drug, with one approved indication, several legitimate hospital uses, and promising early surgical research that is delivered by injection under supervision.
What is not unsupported — what is documented in a standard clinical reference — is the harm. A serotonin interaction with fatal cases described. A contraindication in an inherited condition many people carry unknowingly. A drug that stays in you long enough that the labelling talks in days.
The people selling this are not lying about the pharmacology. Methylene blue does interesting things in a mitochondrion, and you can watch someone explain them very persuasively. They are leaving out the section of the same reference that lists who it can hurt.
This is journalism, not medical advice. If you are taking methylene blue or thinking about it, and especially if you take an antidepressant, an opioid or cough medicine, that is a conversation for a doctor or a pharmacist — who can check your actual medication list, which we cannot.
Related: NAD+ supplements · sea moss benefits · colostrum benefits · does zinc help with colds · every claim we’ve checked
